Willow vs Telos Rx: Supportive program or low-price compounded meds

Willow vs Telos Rx: quick verdict

Willow positions an oral GLP-1 program around structured progress tracking and follow-up support, while Telos Rx highlights lower starting prices for compounded semaglutide and tirzepatide prescribed online; choose Willow for a support-first digital program and Telos Rx for lower starting compounded medication pricing, subject to clinician approval.

Explore Willow’s structured program

How they differ at a glance

This comparison focuses on the most distinctive differences supported by the source: program model and follow-up, starting price, medication type and regulatory notes, treatment eligibility and clinician review, and the presence of progress tracking tools.

Criteria	Willow	Telos Rx
Program model	Telehealth-first weight management program emphasizing a structured journey with follow-up	Clinician-reviewed online prescribing focused on compounded GLP-1 medications
Starting price	299	Semaglutide as low as $99 per month; tirzepatide as low as $139 per month
Progress tracking and follow-up	Progress tracking tools and follow-up consultations included in program description	Not described as a structured follow-up program in captured evidence
Medication type	Oral GLP-1 program; compounded medications, when offered, are not FDA-approved	Compounded semaglutide and tirzepatide prescribed online; compounded medications are not FDA-approved
Eligibility and approval	Treatment available only when a licensed clinician determines it is medically appropriate	Prescribed only after review by a US-licensed provider; pay $0 if not approved noted

Program model and follow-up: Willow centers on support

Willow frames its oral GLP-1 offering as a structured weight management journey rather than a medication subscription. The source repeatedly highlights progress tracking tools and follow-up consultations and states the program is telehealth-first with a licensed telehealth team. Telos Rx, by contrast, is presented as clinician-reviewed online prescribing of compounded semaglutide and tirzepatide with less captured emphasis on ongoing digital follow-up.

See Willow’s telehealth and tracking features

Pricing: higher entry point versus lower starting costs

Willow lists a starting price of 299. Telos Rx publishes semaglutide as low as $99 per month and tirzepatide as low as $139 per month, with language that your price depends on your plan and that you may pay $0 if not approved. The captured evidence also notes cancel anytime, no penalties for Telos Rx. The comparison preserves those qualifiers exactly as presented.

Check Telos Rx pricing and medications

Medication and regulatory notes

Both sources include regulatory qualifiers about compounded medications. Willow states that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Telos Rx similarly states semaglutide and tirzepatide are compounded medications, prescription-only, and are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. These exact qualifiers are preserved from the captured content.

Eligibility and clinical review

Each provider requires a licensed clinician to determine medical appropriateness before treatment. Willow: treatment is available only when a licensed clinician determines it is medically appropriate. Telos Rx: prescribed only after review by a US-licensed provider and a US-licensed provider decides which molecule is right for you. The comparison keeps those limitations verbatim.

Final comparison: Willow vs Telos Rx

Willow emphasizes a support-first digital program with progress tracking and follow-up and lists a starting price of 299. Telos Rx highlights lower starting monthly prices for compounded semaglutide and tirzepatide, with clinician review required and explicit regulatory notes about compounded medications not being FDA-approved. Choose based on whether you prioritize structured follow-up or lower starting compounded medication pricing, subject to clinician approval.

Choose Willow for structured digital follow-up

Choose Telos Rx for lower starting compounded prices

Choose Willow if…

You want a telehealth-first weight management program that emphasizes progress tracking and follow-up consultations and are comfortable with Willow’s stated starting price of 299 and its note that treatment is available only when a licensed clinician determines it is medically appropriate.

Choose Telos Rx if…

You prioritize lower starting prices for compounded semaglutide or tirzepatide as listed, understand those medications are compounded and not FDA-approved, and will confirm eligibility, total cost, renewal terms and state availability with a US-licensed provider before enrollment.